Cantitate/Preț
Produs

Therapeutic Targets – Modulation, Inhibition and Activation

Autor LM Botana
en Limba Engleză Hardback – 7 iun 2012
Providing insight into where the next generations of drugs are likely to emerge, this book describes the pharmacology of therapeutically undefined targets and potential applications. In some cases, there are no defined drugs to modulate some of the targets, and in other cases inhibition or activation will render different therapeutic uses. Chapters cover specific biochemical targets like kinases, phosphatases, phosphodiesterases, and potassium channels. Because different diseases can require their own targeting strategies, the book has chapters on the strategies for targeting Alzheimer's, diabetes, pain, and inflammation.
Citește tot Restrânge

Preț: 81465 lei

Preț vechi: 120035 lei
-32% Nou

Puncte Express: 1222

Preț estimativ în valută:
15589 16462$ 12973£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780470587195
ISBN-10: 0470587199
Pagini: 494
Dimensiuni: 164 x 237 x 31 mm
Greutate: 0.84 kg
Editura: Wiley
Locul publicării:Hoboken, United States

Public țintă

Pharmacologists, biochemists, medicinal chemists, pharmaceutical and biomedical researchers.

Cuprins


Notă biografică

Luis M. Botana was Director of the Department of Pharmacology at the University of Santiago de Compostela (USC), Director of the European Union Reference Laboratory for Marine Biotoxins, and scientific advisor to the drug company LCIFGA. The author of 200 papers and 15 patents, Dr. Botana is the editor of several other books, including Phycotoxins: Chemistry and Biochemistry, published by Wiley (2007). Mabel Loza is Professor of Pharmacology at the University of Santiago de Compostela (USC). She created the USEF Drug Screening Platform, with more than ten years of experience in public and private mixed early drug discovery programs.

Descriere

Providing insight into where the next generations of drugs are likely to emerge, this book describes the pharmacology of therapeutically undefined targets and potential applications. In some cases, there are no defined drugs to modulate some of the targets, and in other cases inhibition or activation will render different therapeutic uses.